無料プレビュー

PROCEPT BioRobotics Corporation (PRCT) · NASDAQ Global Market

プロフィール

PROCEPT BioRobotics is a surgical robotics company that develops, manufactures and sells the AquaBeam Robotic System and HYDROS Robotic System for minimally invasive urologic surgery, specifically for treating benign prostatic hyperplasia (BPH). The systems deliver proprietary Aquablation therapy, which combines image guidance, personalized treatment planning, automated robotics and heat-free waterjet ablation. The company sells primarily to hospitals and ambulatory surgery centers in the United States and internationally through direct sales and distribution partnerships, with products reimbu

主要指標

株価: $17.90 (-0.06%)
時価総額: 10億ドル
PER（今期予想）: -10.7
PBR: 3.0
配当利回り: —
52週レンジ: $16.66 – $38.11
業種: Healthcare / Medical - Devices
上場: NASDAQ Global Market
構成銘柄: —

比較会社: ABT Abbott Laboratories、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、EW Edwards Lifesciences Corporation、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.、PHG Koninklijke Philips N.V.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-03 · 更新: 2026-10-09